Charlotte's Web Q4 rev $13.3M (+4.7% YoY), net loss $11.5M; announces BAT debenture conversion & CMMI pilot

Charlotte's Web Holdings, Inc.

2026-Q1 EPS reported -$0.08 revenue$11,159,000

Q4 2025 revenue $13.3M, up 4.7% YoY; net loss $11.5M ($0.07 loss per share).
Full-year 2025 revenue $49.9M (+0.5% YoY); net loss $29.7M ($0.19 per share).
BAT to convert C$75.3M debenture + $10M new equity, holding ~40% of shares; subject to TSX and shareholder approval.
Charlotte's Web selected as CBD launch partner for CMMI Medicare pilot; CMS BEI guidance allows up to $500/beneficiary annually starting April 2026.
DeFloria (33% owned) cleared by FDA for Phase 2 trial of AJA001 for autism irritability; expects mid-2026 start.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.